Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuromodulation Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuromodulation Market, by Technology, 2018-2027 (USD Billion)
1.2.3. Neuromodulation Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neuromodulation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neuromodulation Market Dynamics
3.1. Neuromodulation Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neuromodulation Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neuromodulation Market, by Technology
5.1. Market Snapshot
5.2. Global Neuromodulation Market by Technology, Performance - Potential Analysis
5.3. Global Neuromodulation Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
5.4. Neuromodulation Market, Sub Segment Analysis
5.4.1. Internal Neuromodulation
5.4.2. External Neuromodulation
Chapter 6. Global Neuromodulation Market, by Application
6.1. Market Snapshot
6.2. Global Neuromodulation Market by Application, Performance - Potential Analysis
6.3. Global Neuromodulation Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Neuromodulation Market, Sub Segment Analysis
6.4.1. Parkinson's Disease
6.4.2. Epilepsy
6.4.3. Depression
6.4.4. Dystonia
6.4.5. Pain Management
6.4.6. Others
Chapter 7. Global Neuromodulation Market, Regional Analysis
7.1. Neuromodulation Market, Regional Market Snapshot
7.2. North America Neuromodulation Market
7.2.1. U.S. Neuromodulation Market
7.2.1.1. Technology breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuromodulation Market
7.3. Europe Neuromodulation Market Snapshot
7.3.1. U.K. Neuromodulation Market
7.3.2. Germany Neuromodulation Market
7.3.3. France Neuromodulation Market
7.3.4. Spain Neuromodulation Market
7.3.5. Italy Neuromodulation Market
7.3.6. Rest of Europe Neuromodulation Market
7.4. Asia-Pacific Neuromodulation Market Snapshot
7.4.1. China Neuromodulation Market
7.4.2. India Neuromodulation Market
7.4.3. Japan Neuromodulation Market
7.4.4. Australia Neuromodulation Market
7.4.5. South Korea Neuromodulation Market
7.4.6. Rest of Asia Pacific Neuromodulation Market
7.5. Latin America Neuromodulation Market Snapshot
7.5.1. Brazil Neuromodulation Market
7.5.2. Mexico Neuromodulation Market
7.6. Rest of The World Neuromodulation Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boston Scientific Corporation
8.2.3. Medtronic PLC
8.2.4. Nevro Corporation
8.2.5. Neuropace Inc.
8.2.6. Neurosigma Inc.
8.2.7. Neuronetics Inc.
8.2.8. LivaNova PLC
8.2.9. Nuvectra
8.2.10. Synapse Biomedical Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption